Aimei Health Technology Co., Ltd.
AFJKRNasdaq
$0.09
↓ -24.8%Jul 17 close · end-of-day
Price
1Y↓ -76.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
$920,546.00
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-22.0%
ROIC
—
Debt / Equity
—
Net Cash
—
Return 1Y
-76.9%
Company profile
We are a blank check company newly incorporated as a Cayman Islands exempted company on April 27, 2023. Our executive offices are located at 10 East 53rd Street, Suite 3001, New York, NY.
- CEO
- Juan Fernandez Pascual
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Headquarters
- New York
Earnings
AFJKR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Operating income | — | -$1.1M | -$835,759.00 |
| Net income | — | $2.6M | $1.1M |
| Diluted EPS | — | — | — |
| Operating cash flow | — | -$672,289.00 | -$565,100.00 |
| Free cash flow | — | — | — |
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$309,114.00 | -$200,019.00 | -$402,021.00 | -$413,414.00 | -$41,604.00 | -$130,152.00 | -$250,589.00 | -$61,984.00 |
| Net income | $609,092.00 | $743,510.00 | $444,113.00 | $184,662.00 | $424,970.00 | $352,019.00 | $98,117.00 | $45,440.00 |
| Diluted EPS | — | — | — | — | — | — | — | — |
| Operating cash flow | -$256,242.00 | -$53,946.00 | -$195,131.00 | -$224,009.00 | -$201,750.00 | -$96,109.00 | -$43,232.00 | -$74,613.00 |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Dec 10, 2025
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.